Advances in stem cell research and genetic engineering are paving the way for more effective and targeted bone marrow transplantation options. Innovations such as CRISPR technology and personalized medicine promise to reduce the risks of complications and enhance the efficacy of BMT. Moreover, ongoing research into minimizing toxic exposure and improving post-transplant care will continue to evolve, potentially transforming BMT into a safer and more accessible treatment option for patients affected by toxic exposure.
